Search Within

Sarat Chandarlapaty

  1. "Monica Morrow"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Breast Medicine Service (7)
  3. Department of Medicine (7)
  4. GSK Faculty (7)
  5. Human Oncology and Pathogenesis Program (7)
  6. Solid Tumor Oncology Division (7)

More Groups

People
  1. Monica Morrow (7)
  2. Neal Rosen (5)
  3. Rita Sakr (5)
  4. Tari King (5)
  5. Dilip Giri (4)
  6. Victor Andrade (4)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2012 (2)
  4. 2011 (1)
  5. 2010 (2)
Publications
  1. Cancer Research (5)
  2. Annals of Oncology (1)
  3. Clinical Cancer Research (1)
Publishers
  1. American Association for Cancer Research (6)
  2. Oxford University Press (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq
    Meeting Abstract

    Cabel, L.; An, J. A. R.; Kurtz, D.; Ross, D.; Dikoglu, E.; Chen, Y.; Murphy, K.; Szuhany, K.; Stowell, S. L.; Maloney, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Molecular predictors for type of recurrence following conservative treatment for DCIS
    Meeting Abstract

    Sakr, R. A.; Andrade, V. P.; Chandarlapaty, S.; Giovanni, C.; Giri, D.; Heguy, A.; De Brot, M.; Olvera, N.; Muhsen, S.; Koslow, S.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer
    Journal Article

    Chandarlapaty, S.; Sakr, R. A.; Giri, D.; Patil, S.; Heguy, A.; Morrow, M.; Modi, S.; Norton, L.; Rosen, N.; Hudis, C.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Can PI3K/AKT pathway mutations predict for type of recurrence after conservative treatment for DCIS
    Meeting Abstract

    Sakr, R. A.; Andrade, V. P.; Muhsen, S.; Chandarlapaty, S.; Giri, D.; Olvera, N.; Paik, W.; Goldberg, J. I.; Van Zee, K. J.; Rosen, N.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • PI3K mutations are more common in low grade DCIS
    Meeting Abstract

    Sakr, R.; Chandarlapaty, S.; Andrade, V.; Giri, D.; Muhsen, S.; Paik, W.; Morrow, M.; Rosen, N.; King, T.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Alternate mechanisms of PI3K pathway activation among subtypes of ductal carcinoma in situ suggest distinct pathways for progression to invasive disease
    Meeting Abstract

    Sakr, R.; Chandarlapaty, S.; Barbashina, V.; Andrade, V.; Heguy, A.; Morrogh, M.; Olvera, N.; Paik, W.; Arroyo, C.; Morrow, M.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save